The fall in RD investment by leading players in the US, at 5.1%, was twice as sharp as in the EU, but the worldwide reduction was lower, at 1.9%.
USA juhtivate tegijate teadus- ja arendustegevusalased investeeringud vähenesid kaks korda rohkem kui ELis (5,1%), kuid ülemaailmne vähenemine oli väiksem (1,9%).